Abeona Therapeutics Inc.
ABEO· Nasdaq
Released May 10, 2019, after the close
10-Q filed May 10, 2019, 40 days after period end · 0001144204-19-025271
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Revenue | $0.00 | $531.00K | $186.00K | $235.00K |
| Net Income | -$18.56M | -$10.53M | -$5.25M | -$5.54M |
| EPS Diluted |
Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR
| -$0.39 |
| -$0.22 |
| -$0.13 |
| -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.